Overview


According to FutureWise analysis the market for aminoglycosides in 2023 is US$ 1.74 billion, and is expected to reach US$ 1.87 billion by 2031 at a CAGR of 3.70%.

Aminoglycosides are a class of antibiotics that are used to treat various bacterial infections. The term "aminoglycosides" is derived from their chemical structure, which consists of amino groups and sugar molecules. These antibiotics are bactericidal, meaning they kill bacteria rather than just inhibiting their growth. Aminoglycosides work by binding to the bacterial ribosome, which is the cellular machinery responsible for protein synthesis. Once bound, they interfere with the ribosome's ability to read the genetic code, leading to the production of faulty proteins and ultimately causing bacterial cell death.

These antibiotics are particularly effective against aerobic (oxygen-requiring) Gram-negative bacteria, but they can also be used against some Gram-positive bacteria in combination with other antibiotics. They are often reserved for serious infections caused by bacteria that are resistant to other classes of antibiotics. Commonly used aminoglycosides include gentamicin, amikacin, tobramycin, and streptomycin. Aminoglycosides are typically administered intravenously or intramuscularly, as they are not well absorbed when taken orally. Due to their potent effects and potential for side effects, aminoglycosides are usually used for short-term treatment and careful monitoring of blood levels is required to prevent toxicity, especially to the kidneys and ears. Because of this, they are typically prescribed in hospital settings and reserved for severe infections where their benefits outweigh the risks.

FutureWise Market Research has published a report that provides an insightful analysis of Aminoglycosides Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that Aminoglycosides Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Kremoint Pharma Pvt. Ltd
  • Vega Pharma Ltd.
  • Jiangxi Bolai Pharmacy Co., Ltd.
  • Xian Wison Biological Technology Co., Ltd.
  • Hangzhou Uniwise International Co., Ltd.
  • HuvePharma
  • Yi Chang Veterinary Medicine Factory
  • Medson Pharmaceuticals
  • Medico Remedies Pvt. Ltd.
  • Cipla Limited
  • Pfizer Inc.
  • Allergan plc
  • Novartis AG
  • Johnson and Johnson
  • Bristol Myers Squibb Company

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Aminoglycosides Market:

  • In March 2022, Padagis has launched the AB-rated generic version of Tobradex® Ophthalmic Suspension after receiving the FDA's approval. This medication is exclusively formulated to treat steroid-responsive inflammatory ocular conditions.

The COVID-19 outbreak profoundly impacted the healthcare sector, leading to various research endeavors to find potential treatments. Among the drugs scrutinized, aminoglycosides garnered attention for their potential as antiviral agents against SARS-CoV-2, the virus responsible for COVID-19. Studies published in 2021 revealed that aminoglycosides like hygromycin B (hygB) and neomycin demonstrated inhibition of the murine hepatitis virus (MHV) in laboratory settings, indicating their possible utility in developing potent COVID-19 medicinal compounds. An escalating occurrence of animal disease outbreaks also played a role in driving the demand for aminoglycosides. Veterinary medicine increasingly utilized antibiotics, including aminoglycosides, to combat bacterial infections in animals, contributing to the overall market growth. The aminoglycosides market is also being driven by the growing number of bacterial infectious diseases among the elderly population. As people age, their susceptibility to bacterial infections increases, leading to a higher demand for antibiotics like aminoglycosides, known for their bactericidal activity against specific bacteria. Antibiotic resistance and multidrug-resistant organisms (MRO) present a pressing healthcare challenge. To tackle this issue, the consumption of broad-spectrum antibiotics, including aminoglycosides, has risen considerably. These drugs are often employed as a secondary line of defence against infections resistant to standard antibacterial agents.

The burden of tuberculosis (TB) has also been a driving force in the demand for aminoglycosides, particularly in low-income countries where TB incidence remains alarmingly high. The effectiveness of aminoglycosides, especially against mycobacteria, makes them a critical component in combating this infectious disease. However, the market growth of aminoglycosides may encounter limitations due to their associated side effects. Drugs in this class, though effective, can lead to severe ototoxicity, nephrotoxicity, and neuromuscular blockade. As a result, the prescription rate of aminoglycosides might decrease as healthcare professionals balance their benefits with potential risks, especially in long-term treatments.

By Product

  • Neomycin
  • Streptomycin
  • Gentamicin
  • Kanamycin
  • Tobramycin
  • Amikacin
  • Others

By Route of Administration

  • Feed
  • Injectable (parenteral)
  • Intra-mammary
  • Oral
  • Topical

By Application

  • Veterinary
  • Skin Infection
  • Respiratory diseases
  • UTI and Pelvic Diseases
  • Other diseases

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022. The market for aminoglycosides in North America is rapidly growing due to various reasons. These include the increasing occurrence of bacterial infections, a rising need for quick identification and treatment of infectious diseases, and government support in infection prevention. According to a study carried out in August 2020, over half of the 1,700+ COVID-19 patients who received treatment at 38 hospitals in Michigan were given early antibiotic therapy. This is a positive sign for market expansion, given the surge in healthcare spending in the area. The World Health Organization's 2021 report indicates that achieving the global target set in 2018 for TB prevention, diagnosis, treatment, and care will necessitate an annual budget of USD 13 billion. Funding and government initiatives are expected to drive the demand for aminoglycosides in preventing infectious diseases. The United Nations' Sustainable Development Goals aim to eradicate the tuberculosis epidemic by 2030, which will further boost the growth of the North American market throughout the forecast period.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants
  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth
  • To provide with an exhaustive analysis on the Aminoglycosides Market By Product, By Route of Administration, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Aminoglycosides Market Variables, Trends and Scope
    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Aminoglycosides Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Aminoglycosides Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Aminoglycosides Market, By Product Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Neomycin
        2. Streptomycin
        3. Gentamicin
        4. Kanamycin
        5. Tobramycin
        6. Amikacin
        7. Others

  • 8.   Aminoglycosides Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Feed
        2. Injectable (parenteral)
        3. Intra-mammary
        4. Oral
        5. Topical

  • 9.   Aminoglycosides Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Veterinary
        2. Skin Infection
        3. Respiratory diseases
        4. UTI and Pelvic Diseases
        5. Other diseases

  • 10.   North America Aminoglycosides Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Aminoglycosides Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Aminoglycosides Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Aminoglycosides Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Kremoint Pharma Pvt. Ltd.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Vega Pharma Ltd.
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Jiangxi Bolai Pharmacy Co., Ltd.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Xian Wison Biological Technology Co., Ltd.
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Hangzhou Uniwise International Co., Ltd.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. HuvePharma
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Yi Chang Veterinary Medicine Factory
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Medson Pharmaceuticals
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Medico Remedies Pvt. Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Cipla Limited
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Pfizer Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Allergan plc
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Novartis AG
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. Johnson and Johnson
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. Bristol Myers Squibb Company
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients